JPMorgan Chase & Co. Has $5.84 Million Stock Holdings in U.S. Physical Therapy, Inc. (NYSE:USPH)

JPMorgan Chase & Co. trimmed its position in U.S. Physical Therapy, Inc. (NYSE:USPH) by 2.5% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 69,017 shares of the company’s stock after selling 1,744 shares during the quarter. JPMorgan Chase & Co. owned approximately 0.46% of U.S. Physical Therapy worth $5,841,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of the company. Principal Financial Group Inc. raised its stake in U.S. Physical Therapy by 1.0% in the third quarter. Principal Financial Group Inc. now owns 79,817 shares of the company’s stock valued at $6,755,000 after buying an additional 766 shares during the period. Geode Capital Management LLC increased its holdings in shares of U.S. Physical Therapy by 1.3% during the 3rd quarter. Geode Capital Management LLC now owns 343,073 shares of the company’s stock worth $29,040,000 after acquiring an additional 4,477 shares during the last quarter. Y Intercept Hong Kong Ltd bought a new stake in U.S. Physical Therapy in the 3rd quarter valued at $573,000. MML Investors Services LLC raised its stake in U.S. Physical Therapy by 12.7% in the 3rd quarter. MML Investors Services LLC now owns 11,826 shares of the company’s stock valued at $1,001,000 after acquiring an additional 1,329 shares during the period. Finally, Southernsun Asset Management LLC lifted its holdings in U.S. Physical Therapy by 10.5% during the 3rd quarter. Southernsun Asset Management LLC now owns 547,111 shares of the company’s stock valued at $46,302,000 after purchasing an additional 52,062 shares during the last quarter.

Insider Activity

In other news, Director Nancy Ham sold 1,172 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $96.72, for a total transaction of $113,355.84. Following the sale, the director now directly owns 1,112 shares of the company’s stock, valued at approximately $107,552.64. This represents a 51.31 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, insider Eric Joseph Williams sold 2,000 shares of the business’s stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $95.84, for a total value of $191,680.00. Following the completion of the transaction, the insider now directly owns 14,814 shares of the company’s stock, valued at approximately $1,419,773.76. This trade represents a 11.89 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 7,412 shares of company stock worth $706,605. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Trading Down 1.1 %

USPH stock opened at $88.72 on Friday. U.S. Physical Therapy, Inc. has a 52 week low of $76.18 and a 52 week high of $113.63. The company has a debt-to-equity ratio of 0.27, a quick ratio of 1.78 and a current ratio of 1.78. The company’s 50-day simple moving average is $92.80 and its 200 day simple moving average is $88.96. The company has a market capitalization of $1.34 billion, a PE ratio of 94.38, a price-to-earnings-growth ratio of 3.58 and a beta of 1.48.

U.S. Physical Therapy Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Friday, November 15th were issued a dividend of $0.44 per share. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.76 annualized dividend and a dividend yield of 1.98%. U.S. Physical Therapy’s dividend payout ratio is presently 187.23%.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. JMP Securities initiated coverage on shares of U.S. Physical Therapy in a report on Monday, December 16th. They issued an “outperform” rating and a $113.00 price objective on the stock. Barrington Research reiterated an “outperform” rating and issued a $108.00 price target on shares of U.S. Physical Therapy in a research note on Thursday, November 21st. JPMorgan Chase & Co. increased their price target on shares of U.S. Physical Therapy from $117.00 to $120.00 and gave the company an “overweight” rating in a report on Tuesday, December 3rd. Citizens Jmp upgraded U.S. Physical Therapy to a “strong-buy” rating in a report on Monday, December 16th. Finally, Bank of America upgraded U.S. Physical Therapy from a “neutral” rating to a “buy” rating and increased their target price for the stock from $100.00 to $115.00 in a research note on Monday, December 16th. One research analyst has rated the stock with a hold rating, four have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, U.S. Physical Therapy currently has an average rating of “Buy” and an average price target of $114.00.

About U.S. Physical Therapy

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.